Discover 1,443 paid clinical trials in St. Petersburg, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,443
Dry Needling in Multiple Sclerosis
for
Multiple Sclerosis
Location: Tampa FL
Sponsor: University of South Florida
Sex: All
Age: 18 - 70+
Code: NCT07615725
Recruiting
Modular Approach for Autism Programs in Schools
for
Autism Spectrum Disorder
Location: Tampa FL, Rochester NY, Randolph MA
Sponsor: May Institute
Sex: All
Age: 5 - 12
Code: NCT04533607
Recruiting
IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)
for
Non Small Cell Lung Cancer
Location: Saint Petersburg FL, Tampa FL, Houston TX, Madison WI
Sponsor: Innate Pharma
Sex: All
Age: 18+
Code: NCT05742607
Phase2, Recruiting
Adjuvant Steroid Outcomes in Idiopathic Subglottic Stenosis
for
Idiopathic Subglottic Stenosis
Location: Tampa FL, Nashville TN, Baltimore MD, Iowa City IA,
Sponsor: Johns Hopkins University
Sex: All
Age: 18 - 70+
Code: NCT07228104
Phase3, Recruiting
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
for
Pancreatic Cancer
Location: Tampa FL, Augusta GA, Birmingham AL, Spartanburg SC,
Sponsor: University of Louisville
Sex: All
Age: 18+
Code: NCT02674100
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors
Location: Tampa FL, Atlanta GA, Memphis TN, Houston TX,
Sponsor: Westat
Sex: All
Age: 14 - 24
Code: NCT07728123
Recruiting
Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy
for
Friedreich Ataxia, Cardiomyopathy, Secondary
Location: Tampa FL
Sponsor: Lexeo Therapeutics
Sex: All
Age: 6+
Code: NCT07721025
Phase2, Recruiting
Evaluation of the Spark of Duval Intervention
for
Teen Pregnancy Prevention
Location: Tampa FL
Sponsor: University of South Florida
Sex: All
Age: 11 - 17
Code: NCT04044027
Recruiting
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)